Search

everythinglearnresearchcommunity

for

Search:↓

Late onset SLE has different symptoms and antibody profiles compared to young onset SLE.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Early diagnosis and treatment of nail and skin conditions can improve health and appearance.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

Researchers created a model to understand heart aging, highlighting key genes and pathways, and suggesting miR-208a as a potential heart attack biomarker.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Recent selection on immune response genes was identified across seven ethnicities.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

The document is a detailed medical reference on skin and genetic disorders.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

New therapies are being developed that target integrin pathways to treat various diseases.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Platelet-derived bio-products help in wound healing and tissue regeneration but lack standardized methods, and their use in medicine is growing.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.